Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
about
Early prediction of severe twin-to-twin transfusion syndromeImpact of fetal echocardiography.The distribution of fetal nuchal translucency thickness in normal Korean fetuses.Fetal echocardiography for congenital heart disease diagnosis: a meta-analysis, power analysis and missing data analysis.The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.Fetal cardiac abnormalities and their association with aneuploidy.Screening for Down's syndrome. Antenatal screening has human costs.Antenatal diagnosis of heart diseaseAdverse pregnancy outcomes after abnormal first-trimester screening for aneuploidyThe nuchal translucency and the fetal heart: a literature review.Increased nuchal translucency in euploid fetuses--what should we be telling the parents?One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester.Osteogenesis imperfecta and other skeletal dysplasias presenting with increased nuchal translucency in the first trimester.Down's syndrome screening: a controversial test, with more controversy to come!Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester.What women want: lead considerations for current and future applications of noninvasive prenatal testing in prenatal carePregnancy and congenital heart diseaseCongenital nephrotic syndrome presenting with increased nuchal translucency in the first trimester.Diagnosis of cardiac defects: where we've been, where we are and where we're going.Ultrasound in prenatal diagnosis: polemics around routine ultrasound screening for second trimester fetal malformations.Increased fetal nuchal translucency at 11-14 weeks.Increased nuchal translucency in fetuses with a normal karyotype.2014 First-trimester ultrasound forum from the Korean Society of Ultrasound in Obstetrics and Gynecology.Prenatal diagnosis of hypoplastic left heart syndrome and trisomy 18 in a fetus with normal nuchal translucency and abnormal ductus venosus blood flow at 13 weeks of gestation.Improving the effectiveness of routine prenatal screening for major congenital heart defects.Clinical impact of first and early second trimester fetal echocardiography on high risk pregnanciesPrenatal Aneuploidies Computerized Screening (SCA TEST): a pilot study on 1000 women.Long-term outcome of children born after a first-trimester measurement of nuchal translucency at the 99th percentile or greater with normal karyotype: a prospective study.The clinical evaluation and pregnancy outcome of euploid fetuses with increased nuchal translucency.Does nuchal translucency have a role in fetal cardiac screening?Congenital heart disease and aneuploidy.Routine fetal cardiac screening: what are we doing and what should we do?First-trimester screening: an overview.The mystery of nuchal translucency.Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16,383 fetuses.Intracardiac Doppler assessment of left valve inflow in first-trimester fetuses with increased nuchal translucency: preliminary observations in trisomy 21.3D and 4D ultrasound in fetal cardiac scanning: a new look at the fetal heart.First trimester ultrasonography in screening and detection of fetal anomalies.Fetal counselling for congenital malformations.A prospective two years study of first trimester screening for Down syndrome
P2860
Q28145096-4D01C7F4-13F5-44FE-9974-D2991CA22662Q30482607-CF607420-D4C6-4ADE-8760-CDC2085CA73AQ30483311-BE1A03D9-7C54-495F-A3E6-7804EBF70ED9Q30855324-8EC61CB7-3133-4D3F-BDE0-0CB1D1DB108AQ30909540-82FD16F4-269D-49A0-9ECE-C16DC0AA7062Q33693755-C06F4A7F-F975-4294-A0F0-56815E7FA3F8Q33808608-42607D8F-E108-4560-B511-8D3FCA39E8F7Q33839214-25F9D702-F108-4221-9C04-0A5822263131Q34002446-871FC3B2-F677-475A-AEF0-FC0C5588F003Q34017264-CE754D49-76FF-4BCE-B51F-A4FB851B56CEQ34020874-A1CDBB52-7928-4BFF-8E58-A67377429F7BQ34058307-950599C5-4C5B-4ACA-9979-6F9EA80F3806Q34165098-68CDDD88-5606-420C-B6E1-5595DA218822Q34193225-D34E82F2-BD53-4D83-8656-1C655BDE4556Q34328382-AFD17C1D-8CCF-41F1-B1E0-0CB1BD161491Q34330946-0B854EA4-8465-40C9-8066-67A340FF6BD4Q34367032-6D92FA4E-DA74-4D36-BD92-8CD1725C92DDQ34540038-03FD78A2-660E-4EC0-9F91-684CAC971DC2Q34618571-B45FBB52-247B-4722-82D2-2B4724B74F34Q34618578-57B4A865-DFCD-45F9-9A1A-973D736C759BQ34618589-99932A13-BDD3-43AB-A202-0E10F33059ECQ34961682-55A79B7F-C6B9-4CBB-8416-82645EA8A238Q35003251-0FC1ECAA-330D-43FE-B396-7E5BC2783256Q35136749-DB66325D-C2E6-43CF-BE2C-EDDE46CA88DDQ35580453-2DC4CD9D-7191-43CE-9997-D943460D7938Q35582626-7AE7131B-8C92-41AE-9F3E-9212B5C8CEC6Q35843634-722B9076-D527-4438-88AA-D1A482A82FEFQ35914896-EA0AC5A0-132F-46FB-940B-664C46293557Q35915580-69965B45-5FA6-4EAC-8850-34F9534706BCQ35991610-713F575E-F10C-4B53-B162-DF147EEE23A9Q35991619-82D2CF6A-6251-46BA-A0EE-7BC89877EDACQ35991624-50DB5EEC-3A70-4E0A-ACAC-94A504EDD436Q36063021-D473447F-4A67-4D5F-B3EB-9C981921D672Q36385060-4773D491-1A5B-44E1-9D1B-13D24F36C09CQ36484717-97350836-29FD-4D23-B62F-23B41D891F25Q36516561-39C03514-E8D0-4C39-86FC-049534F47736Q36698301-77BF563D-1888-43ED-B39C-A2FE370C9924Q36737302-66242946-2365-4A0A-A2AE-B354F54641B8Q36759093-8E8A1DDD-AF27-42E7-8779-615D8E581BB1Q36869157-459625FA-31B6-4999-AD4F-C0DB53E22159
P2860
Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Using fetal nuchal translucenc ...... population based cohort study.
@en
Using fetal nuchal translucenc ...... population based cohort study.
@nl
type
label
Using fetal nuchal translucenc ...... population based cohort study.
@en
Using fetal nuchal translucenc ...... population based cohort study.
@nl
prefLabel
Using fetal nuchal translucenc ...... population based cohort study.
@en
Using fetal nuchal translucenc ...... population based cohort study.
@nl
P2093
P2860
P356
P1433
P1476
Using fetal nuchal translucenc ...... population based cohort study.
@en
P2093
P2860
P356
10.1136/BMJ.318.7176.81
P407
P577
1999-01-01T00:00:00Z